Enfamil lawsuit update: As of April 2025, the ongoing lawsuits surrounding Enfamil and other infant formulas have garnered significant attention due to allegations that these products contributed to the development of necrotizing enterocolitis (NEC) in premature infants. These baby formula lawsuits, which primarily involve major manufacturers like Enfamil (produced by Mead Johnson) and Similac (produced by Abbott Laboratories), have raised serious concerns about the safety of infant formula and the responsibility of manufacturers to warn consumers about risks.
Table of Contents
What Is Necrotizing Enterocolitis (NEC)?
Necrotizing enterocolitis is a life-threatening gastrointestinal condition that affects premature infants, typically those born before 32 weeks of gestation. The disease causes inflammation and infection in the intestines, which can lead to tissue death and, in severe cases, require surgery to remove damaged portions of the intestines. NEC can also lead to long-term complications, including developmental delays and digestive issues.
The exact cause of NEC is not fully understood, but research has suggested a link between the use of cow’s milk-based infant formulas and an increased risk of developing this condition. In particular, many of the lawsuits against Enfamil and other formula manufacturers argue that these products were a contributing factor to the development of NEC in vulnerable preterm infants.
The Allegations Against Enfamil and Other Formula Manufacturers
The lawsuits involving Enfamil and other formula products focus on claims that these manufacturers failed to adequately warn parents, caregivers, and healthcare professionals about the potential risks associated with using their products, especially for premature infants. While formula is often considered a necessary alternative for infants who cannot be breastfed, the plaintiffs argue that manufacturers should have been more transparent about the dangers of using cow’s milk-based formulas for premature babies.
The main allegations in the lawsuits are as follows:
- Failure to Warn: Enfamil and other formula manufacturers allegedly did not provide sufficient warnings about the risk of NEC in premature infants who were fed cow’s milk-based formulas.
- Negligence: The manufacturers are accused of failing to conduct proper research into the safety of their products for premature infants.
- Product Liability: Plaintiffs claim that Enfamil and other formulas should not have been marketed as suitable for preterm infants without proper safety testing.
While these claims are still under litigation, many families affected by NEC have found hope in the legal process, as courts begin to address whether these manufacturers should be held accountable for the harm caused.
The Current Status of Enfamil Lawsuits
As of 2025, over 680 baby formula lawsuits are pending across the United States, the number is cases is rapidly increasing, and the legal process is evolving. Most of these lawsuits have been consolidated into a multidistrict litigation (MDL), which is a legal mechanism that allows similar cases to be heard together to streamline the process and create consistent rulings.
The MDL Process and Bellwether Trials
In 2024, the Judicial Panel on Multidistrict Litigation consolidated the numerous Enfamil and Similac lawsuits into a single MDL. The cases are overseen by U.S. District Judge Rebecca Pallmeyer in the Northern District of Illinois. This consolidation is critical because it allows a more efficient and coordinated approach to handling the large number of cases.
The MDL has brought together over 683 cases as of early 2025. These lawsuits involve parents of premature infants who developed NEC after being fed Enfamil or Similac. The plaintiffs argue that the companies’ formulas caused or contributed to the development of NEC, and they are seeking compensation for medical expenses, pain and suffering, and other damages.
Bellwether trials are expected to begin in May 2025. These initial trials are critical in setting the stage for the remaining cases in the MDL. They will help determine how juries view the evidence and may influence settlement negotiations. The results of these bellwether trials could shape the direction of future lawsuits, either by leading to substantial settlements or by prompting more rigorous defense tactics from the manufacturers.
Recent Verdicts and Developments
In March 2024, a Missouri jury awarded $60 million to the family of a premature infant who developed NEC after being fed Enfamil. This significant verdict has highlighted the potential financial consequences for manufacturers if they are found liable for the harm caused by their products. It also underscores the seriousness of the claims being made in these lawsuits, as it was one of the first major verdicts in favor of the plaintiffs.
Not all cases have resulted in favorable outcomes for the plaintiffs. In a separate trial, a jury sided with Mead Johnson, the manufacturer of Enfamil, ruling that the company was not liable for the development of NEC in a premature infant. This mixed outcome demonstrates the unpredictability of these cases and the challenges that plaintiffs face in proving causation between formula use and the development of NEC.
Despite these varying outcomes, the mounting number of lawsuits and the significant verdicts suggest that the litigation process will continue to intensify in the coming months.
Implications for Affected Families
For parents and families who have been affected by NEC, the ongoing lawsuits present an important opportunity to seek justice. If your child developed NEC after being fed Enfamil or a similar formula, you may have legal grounds to pursue an NEC baby formula lawsuit for compensation. The damages in these cases can be substantial, as they include medical bills, lost income, long-term care expenses, and compensation for pain and suffering.
However, these cases are complex, and proving causation—linking the formula to the development of NEC—can be challenging. That’s why it’s crucial to have an experienced mass tort attorney by your side. A lawyer will help gather the necessary medical records, expert testimony, and other evidence to support your product liability case and improve your chances of a favorable outcome.
What’s Next for the Enfamil Lawsuits?
Looking ahead, the outcome of the bellwether trials will play a major role in determining the future of these lawsuits. If the plaintiffs are successful, it could prompt settlement discussions, leading to compensation for thousands of affected families. However, if the manufacturers prevail in the bellwether trials, it may set a difficult precedent for future cases.
For now, the litigation process remains ongoing, and families affected by NEC should continue to seek legal counsel. As more information becomes available, it is likely that additional lawsuits will be filed, and the manufacturers will continue to defend themselves vigorously.
If you or someone you know has been affected by NEC after using Enfamil or a similar formula, it is important to consult with a qualified attorney who is experienced in product liability and mass tort litigation. At Ankin Law in Chicago, we are committed to fighting for the rights of families who have suffered due to the negligence of large corporations. Our team has the experience and resources to help you recover the compensation you deserve. Call us at 312-600-0000. Free consults are available to help you start your claim.
